BMYMP News and Press, Bristol-Myers Squibb $2Pr From 09/21/22

Summary Ariel Investments’ 13F portfolio value decreased from $11.27B to $10.02B this quarter. They increased Gentex, Resideo Technologies, and Boyd Gaming while reducing Adtalem Global Education, J. M. Smucker, Aflac, and Trip.com. The top three positions are Baidu, Ph...

Summary Merck's operating income was $5,293 million in Q2 2022, up 37.5% year-over-year. Merck's key medicines have received regulatory approvals from the US and Europe, thereby increasing the number of indications, which will positively affect the company's financial position. ...

Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...

Summary Blueprint has a few recently approved therapies, and has recently sold royalties for over $1 billion. While this limits revenue potential now, the profits can be leveraged back into advancing the pipeline. Blueprint can now be assessed like a pre-commercial biotech wit...

Bristol-Myers Squibb Co (BMY) Morgan Stanley Global Healthcare Conference September 12, 2022, 08:10 ET Company Participants Christopher Boerner - EVP & Chief Commercialization Officer Conference Call Participants Terence Flynn - Morgan Stanley Prese...

The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event. For further details see: Bristol-Myers Squibb (BMY) Investor Presentations - Slideshow

Bristol-Myers Squibb Company (BMY) Citi’s 17th Annual BioPharma Conference September 08, 2022 08:50 AM ET Company Participants Adam Lenkowsky - Head of U.S. Commercialization Roland Chen - Head of Cardiovascular Development Tim Powers - Head of Investor Re...

Summary Silver Ring Value Partners provides investment advisory services. The Company offers portfolio management, financial planning, and trading services. Silver Ring Value Partners serves investors in the State of Massachusetts. At the end of June 2022 the portfolio was very at...

ETNB stock has remained depressed for a long time. Not even solid SHTG data could change that. 89bio's NASH data next year may help. I covered 89bio ( ETNB ) in early 2021, and the stock is down 75% since then, which gives me a reason to take another look at this com...

An all-stock portfolio is usually a risky bet for retirees due to sequence of returns risk and inflation. That said, we can arrange stocks by sectors to better prepare for bear markets and any economic environment. It's the all-weather retirement stock portfolio. An all-...